Free Trial

CX Institutional Reduces Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Select Medical logo with Medical background

CX Institutional lessened its holdings in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 77.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 34,821 shares of the health services provider's stock after selling 121,578 shares during the period. CX Institutional's holdings in Select Medical were worth $1,214,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of SEM. GAMMA Investing LLC lifted its stake in Select Medical by 16.6% in the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock worth $81,000 after acquiring an additional 330 shares during the last quarter. Foster & Motley Inc. raised its stake in Select Medical by 3.1% in the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider's stock valued at $426,000 after buying an additional 370 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Select Medical by 6.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider's stock worth $198,000 after acquiring an additional 405 shares in the last quarter. Arizona State Retirement System increased its holdings in shares of Select Medical by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider's stock valued at $1,071,000 after acquiring an additional 593 shares during the last quarter. Finally, Hexagon Capital Partners LLC raised its position in shares of Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider's stock worth $27,000 after acquiring an additional 645 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company's stock.

Analyst Upgrades and Downgrades

SEM has been the subject of several research analyst reports. Bank of America started coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a "buy" rating and a $42.00 target price for the company. Benchmark restated a "buy" rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, September 6th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $39.00.

View Our Latest Stock Report on SEM

Select Medical Price Performance

Shares of NYSE SEM traded down $0.06 during trading on Thursday, hitting $34.29. 240,208 shares of the company were exchanged, compared to its average volume of 522,326. The company has a market cap of $4.46 billion, a price-to-earnings ratio of 16.41, a PEG ratio of 2.09 and a beta of 1.41. Select Medical Holdings Co. has a 1 year low of $21.28 and a 1 year high of $40.50. The firm's fifty day moving average price is $34.30 and its 200 day moving average price is $33.66. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 1.09.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.61 by ($0.01). The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.50%. During the same quarter in the previous year, the business posted $0.61 earnings per share. Select Medical's revenue was up 5.1% on a year-over-year basis. On average, sell-side analysts expect that Select Medical Holdings Co. will post 2.03 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were given a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date of this dividend was Wednesday, August 14th. Select Medical's dividend payout ratio is currently 23.92%.

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Recommended Stories

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

→ Election rigged? We caught them red-handed… (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Select Medical right now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines